Alnylam Pharmaceuticals, Inc. (0HD2.L) Dividend Yield, History & Forecast

Alnylam Pharmaceuticals, Inc. (0HD2.L) is a Medical - Pharmaceuticals company in the Healthcare sector listed on the London Stock Exchange. The most recent ex-dividend date was March 15, 2022. market capitalization is approximately $42.42B.

Loading quote...

Frequently Asked Questions about Alnylam Pharmaceuticals, Inc. (0HD2.L)

When does Alnylam Pharmaceuticals, Inc. pay its next dividend?
The most recent ex-dividend date was March 15, 2022.
Is Alnylam Pharmaceuticals, Inc. a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Alnylam Pharmaceuticals, Inc. in?
Alnylam Pharmaceuticals, Inc. (0HD2.L) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry.
Alnylam Pharmaceuticals, Inc. (0HD2.L) Dividend Yield, History & Forecast | Dividend Wealth